{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Richardson",
      "state": "TX",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89954",
      "recalling_firm": "North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding",
      "address_1": "1736 N Greenville Ave",
      "address_2": "",
      "postal_code": "75081-1808",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within United States",
      "recall_number": "D-0781-2022",
      "product_description": "Sermorelin Acetate 1 mg/mL (6 mL) Injection, 6 mL vials, Rx only,  Farmakeio 1736 N Greenville Ave Richardson, TX 75081",
      "product_quantity": "76 vials",
      "reason_for_recall": "Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.",
      "recall_initiation_date": "20220405",
      "center_classification_date": "20220421",
      "termination_date": "20231005",
      "report_date": "20220427",
      "code_info": "Lot #: 32963 BUD: 4/12/2022; 34824 BUD: 5/30/2022; 35130 BUD: 6/7/2022",
      "more_code_info": ""
    }
  ]
}